Articles related to BIPOLAR DISORDER
Recognizing and Treating Acute Agitation in Schizophrenia and Bipolar Disorder Patients (CME)
Enhance your clinical acumen in managing acute agitation in schizophrenia and bipolar disorder patients. Equip yourself with the latest guidelines and treatment options to provide optimal care in emergency settings.
Clinical Pharmacology August 29th 2023
A Study of the Association of Ulcerative Colitis and Bipolar Disorder in an Inpatient Population
This study’s findings challenge existing understanding by revealing an inverse relationship between ulcerative colitis and bipolar disorder in young adult inpatients. The results, based on a vast sample size and national representation, call for further research to uncover the underlying mechanisms and potential therapeutic implications.
Gastroenterology August 22nd 2023
Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression
A recent study on bipolar I depression patients found that extended antidepressant maintenance for 52 weeks did not significantly prevent mood episode relapses compared to an 8-week regimen.
Psychiatry August 8th 2023
CME: Bipolar 1 and Bipolar 2 Depression – Timely Diagnosis and Effective Management in 2023 and Beyond
Dig into the essence of diagnosing and managing bipolar depression to enrich your practice and improve patient well-being. Bipolar depression often presents an intricate diagnostic challenge due to its symptomatology, leading to delays in accurate diagnosis and frequent misdiagnoses as unipolar depression. Consequently, patients run the risk of suboptimal treatment, highlighting the need for more effective strategies in diagnosing and managing bipolar depression. Traditional therapeutic approaches, including monotherapy and adjunctive therapies, pose certain limitations. Notably, these treatments present side-effect concerns, adherence challenges, and substantial relapse rates. For optimal management of bipolar depression, healthcare providers should remain updated on the evolving landscape of newer pharmacological agents. This educational program underscores the importance of timely and accurate diagnosis of bipolar depression, covering both bipolar 1 and 2 depression. The emphasis is placed on differentiating these forms from unipolar depression, a crucial aspect for early recognition and accurate diagnosis. In terms of management, the program introduces evidence-based strategies, comparing monotherapies to adjunctive therapies. It also encourages providers to evaluate current treatment options for their clinical impact. By doing so, practitioners can ensure the development of patient-centered, evidence-based treatment plans. The successful application of these diagnostic and management strategies is expected to reduce the […]
Internal Medicine May 23rd 2023
Schizophrenia and Bipolar Disorder: Improving Adherence and New Therapeutic Updates
Poor adherence to treatment is the biggest predictor in relapse in serious mental illnesses. In this 0.5-CME credit activity, the panel discusses key contributors to the adherence challenge and strategies for improving adherence – including use of newer, better tolerated therapies. Available in video, podcast, and text.
Neurology April 11th 2023
Bipolar I vs. Bipolar II: Major Differences in Diagnosis and Treatment
This interview with Roger McIntyre, MD, professor of psychiatry and pharmacology at the University of Toronto, highlights the key points from his presentation at the 2022 NEI Congress. Dr. McIntyre discusses the different clinical presentations and gives an overview of the most effective pharmacologic treatments for each disorder.
Psychiatry December 13th 2022